Medicare’s $84 Billion Problem Nobody Can Fix

Wooden blocks spelling out MEDICARE on a dark background — $84 BILLION MEDICARE PROBLEM

The Trump administration just handed health insurers a $35 billion windfall while simultaneously signaling the money spigot may soon run dry—a contradiction that reveals the precarious economics of America’s fastest-growing healthcare program.

Story Snapshot

CMS finalized a 7.2% Medicare Advantage payment increase for 2026, far exceeding the 4.3% projected in January and adding $35 billion to insurer coffers
The rate hike represents the largest jump since 2023, despite ongoing scrutiny over $84 billion in annual overpayments driven by diagnosis code manipulation
Trump’s CMS simultaneously proposed a near-flat 0.09% increase for 2027, sparking record industry backlash and warnings of benefit cuts for 35 million seniors
Improper payments reached $23.67 billion in fiscal 2025, with most stemming from unsubstantiated diagnoses that inflate risk scores and government reimbursements
A separate star ratings rule handed insurers an additional $18.6 billion windfall over a decade by reducing quality measurement requirements

The Great Medicare Advantage Payment Paradox

Health insurers received an unexpected gift on April 6, 2026, when the Centers for Medicare and Medicaid Services locked in a 7.2% payment boost for Medicare Advantage plans. The increase translates to $35 billion more than 2025 levels and towers over the industry’s modest expectations.

Traditional Medicare spending growth drove the rate upward by 9.0%, though Biden-era risk model changes clawed back 3.0% and other adjustments shaved another 1.0%. Diagnosis coding trends added 2.1% to the final tally, underscoring how documentation practices continue inflating government payments despite years of reform efforts.

The US Medicare program will pay private insurers 2.48% more in 2027, a meaningful improvement over the initial rates the agency proposed in January https://t.co/ynS7Ip3kK0

— Bloomberg (@business) April 6, 2026

When Zero Percent Feels Like a Death Sentence

The celebration proved short-lived. Just weeks before finalizing 2026’s generous rates, Trump’s CMS proposed a microscopic 0.09% increase for 2027—effectively a freeze that sent insurer stocks tumbling and triggered a lobbying blitz unlike any in Medicare Advantage history.

Industry groups America’s Health Insurance Plans and Better Medicare Alliance warned the flat rate would force benefit cuts for 35 million enrollees. The proposal also tightened risk adjustment rules, tying diagnosis codes to documented patient visits rather than accepting chart reviews alone, a change aimed squarely at the upcoding practices that have padded insurer revenues for years.

The Eighty-Four Billion Dollar Question

Medicare’s independent advisory body MedPAC estimates the government overpays Medicare Advantage plans by roughly 20% compared to what the same patients would cost in traditional Medicare—$84 billion in 2025 alone.

The excess stems from insurers aggressively documenting every possible diagnosis code to inflate their enrollees’ apparent health risks, thereby boosting the risk-adjusted payments they receive.

Federal audits classified $23.67 billion in fiscal 2025 Part C payments as improper, predominantly due to diagnoses lacking adequate medical record support. This isn’t nickel-and-dime accounting error; it represents a fundamental misalignment between what taxpayers fund and the actual care delivered to seniors.

Star Ratings: The Other Eighteen Billion Nobody Noticed

While the payment rate drama consumed headlines, CMS quietly finalized changes to Medicare Advantage star ratings on April 2 that will deliver insurers an $18.6 billion windfall over the next decade. The agency slashed quality measures, making it easier for plans to achieve high ratings that trigger bonus payments.

The final rule proved far more generous than the proposed version, which would have cost insurers $13.2 billion. Combined with the 2026 payment hike, these twin decisions suggest Trump’s team remains sensitive to industry pressure despite tough talk about curbing overpayments and aligning reimbursements with actual patient care rather than paperwork prowess.

The Growth Rate Shell Game

Industry consultants commissioned by Better Medicare Alliance argue that even small tweaks to growth rate assumptions generate massive payment swings—approximately $12 per member per month for each 1% adjustment. Insurers insist they need 4% to 6% annual increases to cover rising medical claims from aging baby boomers.

Yet critics point out Medicare Advantage has operated as a growth engine fueled by taxpayer dollars while delivering questionable value compared to traditional Medicare.

The Trump administration faces a choice: continue the spending trajectory that enriches private insurers or impose the discipline conservatives typically champion when government programs balloon beyond their original scope and cost projections.

The 2026 rate finalization bought insurers breathing room, but the looming 2027 decision will determine whether Trump’s Medicare policy follows his administration’s stated austerity principles or bends to an industry that generated record lobbying comments, funded sympathetic research, and deployed warnings about seniors losing benefits.

The fact that improper payments approached $24 billion in a single year while MedPAC identifies $84 billion in structural overpayments suggests the current system rewards aggressive coding over efficient care.

Traditional conservative principles favor market discipline and eliminating waste; applying those standards to Medicare Advantage would mean embracing tighter payment controls regardless of insurer protests.

The real test arrives when CMS finalizes 2027 rates in the coming weeks—will policy match the tough rhetoric, or will another surprise increase prove that Medicare Advantage’s lobbying machine remains more powerful than any administration’s cost-cutting ambitions?